{"product_id":"cartalax-20mg-vial","title":"Cartalax 20mg vial","description":"\u003cp data-end=\"88\" data-start=\"0\"\u003e\u003cstrong\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e                                               \u003cspan style=\"text-decoration: underline;\"\u003eNOT \u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003e\u003cspan style=\"color: rgb(255, 42, 0); text-decoration: underline;\"\u003eFOR HUMAN CONSUMPTION\u003c\/span\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2 data-end=\"88\" data-start=\"0\"\u003eCartalax (AED \/ AC-4): synthesized cartilage bioregulator peptide \u003c\/h2\u003e\n\u003cp data-end=\"476\" data-start=\"90\"\u003e\u003cbr data-end=\"107\" data-start=\"104\"\u003e\u003cstrong data-end=\"119\" data-start=\"107\"\u003eCartalax\u003c\/strong\u003e is commonly described as a \u003cstrong data-end=\"222\" data-start=\"147\"\u003eshort, synthesized “tissue-specific” peptide bioregulator for cartilage\u003c\/strong\u003e, often referenced as the \u003cstrong data-end=\"280\" data-start=\"248\"\u003etripeptide AED (Ala-Glu-Asp)\u003c\/strong\u003e and\/or \u003cstrong data-end=\"312\" data-start=\"288\"\u003epeptide complex AC-4\u003c\/strong\u003e (marketed in some regions as a \u003cstrong data-end=\"370\" data-start=\"344\"\u003edietary supplement\/BAA\u003c\/strong\u003e, and separately sold by research vendors as a lyophilized peptide). \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-end=\"840\" data-start=\"478\"\u003e\u003cstrong data-end=\"494\" data-start=\"478\"\u003eCore concept\u003c\/strong\u003e\u003cbr data-end=\"497\" data-start=\"494\"\u003eThe “bioregulator” framing is that ultrashort peptides like \u003cstrong data-end=\"564\" data-start=\"557\"\u003eAED\u003c\/strong\u003e may influence \u003cstrong data-end=\"622\" data-start=\"579\"\u003egene expression and reparative programs\u003c\/strong\u003e in cartilage-relevant cells (e.g., MSCs\/chondrocyte-like systems), potentially supporting cartilage homeostasis and repair pathways relevant to degenerative joint\/spine disorders. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-end=\"1116\" data-start=\"1113\"\u003e\n\u003ch2 data-end=\"1188\" data-start=\"1118\"\u003eAdditional benefits now under investigation (Cartalax\/AED-centered)\u003c\/h2\u003e\n\u003cdiv class=\"TyagGW_tableContainer\"\u003e\n\u003cdiv class=\"group TyagGW_tableWrapper flex flex-col-reverse w-fit\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"2802\" data-start=\"1190\"\u003e\n\u003cthead data-end=\"1218\" data-start=\"1190\"\u003e\n\u003ctr data-end=\"1218\" data-start=\"1190\"\u003e\n\u003cth data-col-size=\"md\" data-end=\"1200\" data-start=\"1190\"\u003eBENEFIT\u003c\/th\u003e\n\u003cth data-col-size=\"xl\" data-end=\"1218\" data-start=\"1200\"\u003eKEY TAKE-AWAYS\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"2802\" data-start=\"1229\"\u003e\n\u003ctr data-end=\"1566\" data-start=\"1229\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1274\" data-start=\"1229\"\u003e1) Joint\/spine symptom improvement signals\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"1566\" data-start=\"1274\"\u003eVendor\/bioregulator materials describe \u003cstrong data-end=\"1347\" data-start=\"1315\"\u003epain and symptom improvement\u003c\/strong\u003e in degenerative spine\/joint conditions and report “clinical study” use in osteochondrosis\/osteoarthritis contexts, but details are often not presented as full peer-reviewed RCTs. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1862\" data-start=\"1567\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1610\" data-start=\"1567\"\u003e2) Chondro-\/geroprotective gene programs\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"1862\" data-start=\"1610\"\u003eA chondrogenesis review notes \u003cstrong data-end=\"1663\" data-start=\"1642\"\u003eAED (Ala-Glu-Asp)\u003c\/strong\u003e within cartilage peptide complexes and summarizes effects on \u003cstrong data-end=\"1746\" data-start=\"1725\"\u003eNFκB, IGF1, TNKS2\u003c\/strong\u003e expression in MSC aging models, positioning it as “chondro\/geroprotective.” \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2135\" data-start=\"1863\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1906\" data-start=\"1863\"\u003e3) MSC\/chondrocyte support (preclinical)\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"2135\" data-start=\"1906\"\u003eThe same review links AED to \u003cstrong data-end=\"1971\" data-start=\"1937\"\u003eMSC metabolism\/differentiation\u003c\/strong\u003e and fibroblast proliferation\/apoptosis markers in aging models—used as mechanistic rationale for cartilage repair interest. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2483\" data-start=\"2136\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2174\" data-start=\"2136\"\u003e4) Musculoskeletal recovery concept\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"2483\" data-start=\"2174\"\u003eA scientific lecture\/source (Institute-affiliated) describes Cartalax (AED) as derived from cartilage complex analysis and positioned for \u003cstrong data-end=\"2366\" data-start=\"2314\"\u003earthrosis\/arthritis\/osteochondrosis\/osteoporosis\u003c\/strong\u003eprevention\/adjunct use—again, mostly \u003cstrong data-end=\"2442\" data-start=\"2404\"\u003eprogrammatic + preclinical framing\u003c\/strong\u003e. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2802\" data-start=\"2484\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2530\" data-start=\"2484\"\u003e5) “Cartilage ECM normalization” hypothesis\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"2802\" data-start=\"2530\"\u003eCommercial and institute-adjacent descriptions repeatedly frame Cartalax as supporting \u003cstrong data-end=\"2664\" data-start=\"2619\"\u003econnective tissue\/cartilage normalization\u003c\/strong\u003e, consistent with its positioning as a cartilage bioregulator rather than a receptor agonist drug. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp data-end=\"3181\" data-start=\"2804\"\u003e\u003cstrong data-end=\"2830\" data-start=\"2804\"\u003eEvidence quality note:\u003c\/strong\u003e The most concrete peer-reviewed material you can cite today is \u003cstrong data-end=\"2931\" data-start=\"2894\"\u003emechanistic\/biological discussion\u003c\/strong\u003e (e.g., MSC gene expression effects in review context). Claims of broad clinical benefit often come from \u003cstrong data-end=\"3082\" data-start=\"3036\"\u003enon-RCT marketing\/lecture\/vendor documents\u003c\/strong\u003e rather than widely indexed, high-quality multicenter trials. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-end=\"3186\" data-start=\"3183\"\u003e\n\u003ch2 data-end=\"3223\" data-start=\"3188\"\u003e2) Molecular mechanism of action\u003c\/h2\u003e\n\u003ch3 data-end=\"3290\" data-start=\"3225\"\u003e2.1 “Pharmacodynamics” framing (how it’s typically described)\u003c\/h3\u003e\n\u003cp data-end=\"3561\" data-start=\"3291\"\u003eCartalax\/AED is discussed as an \u003cstrong data-end=\"3345\" data-start=\"3323\"\u003eultrashort peptide\u003c\/strong\u003e potentially capable of \u003cstrong data-end=\"3399\" data-start=\"3369\"\u003emodulating gene expression\u003c\/strong\u003e and cellular programs relevant to cartilage repair and inflammation (as part of the broader peptide bioregulator paradigm). \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"3634\" data-start=\"3563\"\u003e2.2 Down-stream biology (summarized from the chondrogenesis review)\u003c\/h3\u003e\n\u003cdiv class=\"TyagGW_tableContainer\"\u003e\n\u003cdiv class=\"group TyagGW_tableWrapper flex flex-col-reverse w-fit\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"4635\" data-start=\"3635\"\u003e\n\u003cthead data-end=\"3677\" data-start=\"3635\"\u003e\n\u003ctr data-end=\"3677\" data-start=\"3635\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"3645\" data-start=\"3635\"\u003ePATHWAY\u003c\/th\u003e\n\u003cth data-col-size=\"lg\" data-end=\"3666\" data-start=\"3645\"\u003eFUNCTIONAL OUTCOME\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"3677\" data-start=\"3666\"\u003eCONTEXT\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"4635\" data-start=\"3692\"\u003e\n\u003ctr data-end=\"3924\" data-start=\"3692\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3716\" data-start=\"3692\"\u003eNFκB-linked signaling\u003c\/td\u003e\n\u003ctd data-col-size=\"lg\" data-end=\"3896\" data-start=\"3716\"\u003eAED reported to affect \u003cstrong data-end=\"3765\" data-start=\"3741\"\u003eNFκB gene expression\u003c\/strong\u003e in MSC aging models; review suggests relevance to inflammatory regulation in OA contexts. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3924\" data-start=\"3896\"\u003eMSC aging \/ OA rationale\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"4143\" data-start=\"3925\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3932\" data-start=\"3925\"\u003eIGF1\u003c\/td\u003e\n\u003ctd data-col-size=\"lg\" data-end=\"4104\" data-start=\"3932\"\u003eAED reported to stimulate \u003cstrong data-end=\"3984\" data-start=\"3960\"\u003eIGF1 gene expression\u003c\/strong\u003e in MSC aging models (review inference: supports synthetic\/anabolic processes). \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4143\" data-start=\"4104\"\u003eMSC aging \/ tissue repair rationale\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"4393\" data-start=\"4144\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4184\" data-start=\"4144\"\u003eTNKS2 \/ Wnt-related \/ cell metabolism\u003c\/td\u003e\n\u003ctd data-col-size=\"lg\" data-end=\"4359\" data-start=\"4184\"\u003eAED reported to affect \u003cstrong data-end=\"4229\" data-start=\"4209\"\u003eTNKS2 expression\u003c\/strong\u003e (tankyrase-related functions include telomere integrity and Wnt activity, among others). \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4393\" data-start=\"4359\"\u003eCell growth\/metabolism framing\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"4635\" data-start=\"4394\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4428\" data-start=\"4394\"\u003eProliferation\/apoptosis markers\u003c\/td\u003e\n\u003ctd data-col-size=\"lg\" data-end=\"4600\" data-start=\"4428\"\u003eReview cites AED effects on markers like \u003cstrong data-end=\"4496\" data-start=\"4471\"\u003eKi67, caspase-3, MMP9\u003c\/strong\u003e in fibroblast aging models—used to argue reparative potential. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4635\" data-start=\"4600\"\u003eSupportive mechanistic evidence\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"4640\" data-start=\"4637\"\u003e\n\u003ch2 data-end=\"4664\" data-start=\"4642\"\u003e3) Pharmacokinetics\u003c\/h2\u003e\n\u003cp data-end=\"4981\" data-start=\"4665\"\u003eThere isn’t a single authoritative, drug-label PK profile for “Cartalax” because it’s sold in \u003cstrong data-end=\"4786\" data-start=\"4759\"\u003esupplement\/bioregulator\u003c\/strong\u003eformats and \u003cstrong data-end=\"4811\" data-start=\"4799\"\u003eresearch\u003c\/strong\u003e formats. For ultrashort peptides, exposure is typically shaped strongly by \u003cstrong data-end=\"4940\" data-start=\"4887\"\u003eroute, formulation, and degradation by peptidases\u003c\/strong\u003e. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-end=\"4986\" data-start=\"4983\"\u003e\n\u003ch2 data-end=\"5028\" data-start=\"4988\"\u003e4) Pre-clinical and clinical evidence\u003c\/h2\u003e\n\u003ch3 data-end=\"5083\" data-start=\"5030\"\u003e4.1 Mechanistic \/ preclinical evidence (stronger)\u003c\/h3\u003e\n\u003cp data-end=\"5344\" data-start=\"5084\"\u003eA peer-reviewed chondrogenic differentiation review explicitly discusses cartilage peptide complexes containing \u003cstrong data-end=\"5217\" data-start=\"5196\"\u003eAED (Ala-Glu-Asp)\u003c\/strong\u003e and summarizes \u003cstrong data-end=\"5260\" data-start=\"5233\"\u003egene-expression effects\u003c\/strong\u003e in MSC models relevant to aging\/OA biology. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"5412\" data-start=\"5346\"\u003e4.2 Human evidence (weaker \/ often non-standardized reporting)\u003c\/h3\u003e\n\u003cp data-end=\"5756\" data-start=\"5413\"\u003eInstitute-adjacent and vendor PDF materials state that “clinical study” work supports benefit in osteochondrosis\/osteoarthritis\/osteoporosis and post-injury contexts, but these sources typically \u003cstrong data-end=\"5626\" data-start=\"5608\"\u003edo not provide\u003c\/strong\u003e full RCT-grade details in the document itself (randomization, endpoints, blinding, etc.). \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-end=\"5761\" data-start=\"5758\"\u003e\n\u003ch2 data-end=\"5796\" data-start=\"5763\"\u003e5) Emerging clinical interests\u003c\/h2\u003e\n\u003cdiv class=\"TyagGW_tableContainer\"\u003e\n\u003cdiv class=\"group TyagGW_tableWrapper flex flex-col-reverse w-fit\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"6211\" data-start=\"5797\"\u003e\n\u003cthead data-end=\"5827\" data-start=\"5797\"\u003e\n\u003ctr data-end=\"5827\" data-start=\"5797\"\u003e\n\u003cth data-col-size=\"md\" data-end=\"5805\" data-start=\"5797\"\u003eFIELD\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"5817\" data-start=\"5805\"\u003eRATIONALE\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"5827\" data-start=\"5817\"\u003eSTATUS\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"6211\" data-start=\"5842\"\u003e\n\u003ctr data-end=\"6054\" data-start=\"5842\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5888\" data-start=\"5842\"\u003eOsteoarthritis \/ degenerative spine disease\u003c\/td\u003e\n\u003ctd data-end=\"5935\" data-start=\"5888\" data-col-size=\"md\"\u003eSymptom relief + cartilage repair hypothesis\u003c\/td\u003e\n\u003ctd data-end=\"6054\" data-start=\"5935\" data-col-size=\"md\"\u003emostly mechanistic + adjunct\/real-world claims; robust RCT evidence unclear \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"6211\" data-start=\"6055\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"6092\" data-start=\"6055\"\u003e“Geroprotective” cartilage support\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"6136\" data-start=\"6092\"\u003eMSC aging gene programs (NFκB\/IGF1\/TNKS2)\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"6211\" data-start=\"6136\"\u003eearly biology\/translation stage \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"6216\" data-start=\"6213\"\u003e\n\u003ch2 data-end=\"6247\" data-start=\"6218\"\u003e6) Safety and tolerability\u003c\/h2\u003e\n\u003cp data-end=\"6605\" data-start=\"6248\"\u003e\u003cstrong data-end=\"6277\" data-start=\"6248\"\u003eHigh-certainty statement:\u003c\/strong\u003e there is \u003cstrong data-end=\"6312\" data-start=\"6287\"\u003eno FDA\/EMA drug label\u003c\/strong\u003e establishing Cartalax safety\/contraindications in the way there is for approved medicines.\u003cbr data-end=\"6406\" data-start=\"6403\"\u003eSome product documents claim good tolerability\/no side effects, but those statements aren’t a substitute for regulated pharmacovigilance and controlled trials. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-end=\"6639\" data-start=\"6607\"\u003ePractical uncertainties to flag:\u003c\/p\u003e\n\u003cul data-end=\"6880\" data-start=\"6640\"\u003e\n\u003cli data-end=\"6773\" data-start=\"6640\"\u003e\n\u003cp data-end=\"6773\" data-start=\"6642\"\u003e\u003cstrong data-end=\"6678\" data-start=\"6642\"\u003eProduct quality\/sterility\/purity\u003c\/strong\u003e variability across non-regulated supply chains (especially for injectable “research” formats).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6880\" data-start=\"6774\"\u003e\n\u003cp data-end=\"6880\" data-start=\"6776\"\u003e\u003cstrong data-end=\"6801\" data-start=\"6776\"\u003eImmunologic reactions\u003c\/strong\u003e are possible with peptide products (risk depends on formulation\/route\/purity).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"6885\" data-start=\"6882\"\u003e\n\u003ch2 data-end=\"6913\" data-start=\"6887\"\u003e7) Regulatory landscape\u003c\/h2\u003e\n\u003cul data-end=\"7077\" data-start=\"6914\"\u003e\n\u003cli data-end=\"7077\" data-start=\"6914\"\u003e\n\u003cp data-end=\"7077\" data-start=\"6916\"\u003e\u003cstrong data-end=\"6970\" data-start=\"6916\"\u003eInvestigational \/ supplement-marketed bioregulator\u003c\/strong\u003e positioning rather than an approved pharmaceutical indication set. \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"7082\" data-start=\"7079\"\u003e\n\u003ch2 data-end=\"7143\" data-start=\"7084\"\u003e8) Future directions (what would make the claims “real”)\u003c\/h2\u003e\n\u003col data-end=\"7591\" data-start=\"7144\"\u003e\n\u003cli data-end=\"7288\" data-start=\"7144\"\u003e\n\u003cp data-end=\"7288\" data-start=\"7147\"\u003e\u003cstrong data-end=\"7180\" data-start=\"7147\"\u003eWell-designed clinical trials\u003c\/strong\u003e in OA\/degenerative spine disease with standardized endpoints (pain\/function scores, imaging, biomarkers).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7413\" data-start=\"7289\"\u003e\n\u003cp data-end=\"7413\" data-start=\"7292\"\u003e\u003cstrong data-end=\"7321\" data-start=\"7292\"\u003eClear formulation + route\u003c\/strong\u003e standardization (capsule\/lingual vs injectable research peptide are not interchangeable).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7591\" data-start=\"7414\"\u003e\n\u003cp data-end=\"7591\" data-start=\"7417\"\u003e\u003cstrong data-end=\"7439\" data-start=\"7417\"\u003eMechanism bridging\u003c\/strong\u003e (showing that the MSC gene-expression effects translate into cartilage structural\/clinical outcomes in humans). \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003chr data-end=\"7596\" data-start=\"7593\"\u003e\n\u003ch2 data-end=\"7620\" data-start=\"7598\"\u003eSelected references\u003c\/h2\u003e\n\u003cul data-end=\"8183\" data-start=\"7621\"\u003e\n\u003cli data-end=\"7784\" data-start=\"7621\"\u003e\n\u003cp data-end=\"7784\" data-start=\"7623\"\u003e\u003cstrong data-end=\"7648\" data-start=\"7623\"\u003eChondrogenesis review\u003c\/strong\u003e summarizing AED (Ala-Glu-Asp) within cartilage peptide complexes and downstream gene effects: \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7940\" data-start=\"7785\"\u003e\n\u003cp data-end=\"7940\" data-start=\"7787\"\u003e\u003cstrong data-end=\"7821\" data-start=\"7787\"\u003eInstitute-adjacent lecture PDF\u003c\/strong\u003e describing Cartalax (AED) positioning and musculoskeletal pathology context: \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8069\" data-start=\"7941\"\u003e\n\u003cp data-end=\"8069\" data-start=\"7943\"\u003e\u003cstrong data-end=\"7967\" data-start=\"7943\"\u003eCartalax product PDF\u003c\/strong\u003e claiming clinical study usage and listing AC-4 ingredients: \u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8183\" data-start=\"8070\"\u003e\n\u003cp data-end=\"8183\" data-start=\"8072\"\u003e\u003cstrong data-end=\"8141\" data-start=\"8072\"\u003eGeneral peptide bioregulator gene-expression review (background)\u003c\/strong\u003e\u003cspan data-state=\"closed\" class=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"RCpeptides","offers":[{"title":"Default Title","offer_id":52684843680082,"sku":null,"price":40.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1048\/0956\/2450\/files\/Cartalax_20mg.png?v=1770834815","url":"https:\/\/sciencepeptideslab.com\/products\/cartalax-20mg-vial","provider":"Science Peptides Lab","version":"1.0","type":"link"}